Tamsulosin Mylan generics

Tamsulosin Mylan is a generic pharmaceutical product used primarily for the treatment of symptoms related to benign prostatic hyperplasia (BPH). The brand Mylan was originally established in West Virginia, USA, and became one of the world's largest generic drug manufacturers. In 2020, Mylan merged with Upjohn (a division of Pfizer) to form Viatris, a global healthcare company.

Manufacturing of Viatris products occurs across a vast network of facilities worldwide, including major hubs in India, Ireland, and the United States, to serve global markets. The pack shown is an Italian-marketed equivalent medicine, distributed under the corporate branding of Viatris.